Genprex Inc (GNPX)

Genprex Inc (GNPX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.7M; returns 1 day -8.6%, 1 week -14.2%, 1 year -99.1%.

Genprex, Inc. (GNPX) is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The company does not currently generate revenue from product sales, relying instead on financing activities, strategic collaborations, and grants to fund its research and clinical trials.

Groups GNPX belongs to

• Recent Reverse Splits
• Clinical Stage Biotech
• Gene Therapy
• Biotechnology
• Healthcare
• Oncology
• Type 1 Diabetes
• Life Sciences
• Clinical Stage
• Cancer Therapeutics
• Fast Track Designation

GNPX financial model: income statement, cash flow and balance sheet